Host-parasite dynamics and outgrowth of virus containing a single K70R amino acid change in reverse transcriptase are responsible for the loss of human immunodeficiency virus type 1 RNA load suppression by zidovudine.
about
Adherence and drug resistance: predictions for therapy outcome3'-Azido-3'-deoxythymidine (AZT) mediates cross-resistance to nucleoside analogs in the case of AZT-resistant human immunodeficiency virus type 1 variants.A polymorphism at position 400 in the connection subdomain of HIV-1 reverse transcriptase affects sensitivity to NNRTIs and RNaseH activityEstimating HIV-1 fitness characteristics from cross-sectional genotype dataReappearance of an 11-year-old sequence in an HIV-1 infected patient during treatment interruption.Frequency of Drug-Resistant Variants of HIV-1 Coexistent With Wild-Type in Treatment-Naive Patients of IndiaGenotypic changes in human immunodeficiency virus type 1 associated with loss of suppression of plasma viral RNA levels in subjects treated with ritonavir (Norvir) monotherapyGenotypic testing for human immunodeficiency virus type 1 drug resistance.Fitness comparison of thymidine analog resistance pathways in human immunodeficiency virus type 1.A Guide to HIV-1 Reverse Transcriptase and Protease Sequencing for Drug Resistance Studies.Clinical data sets of human immunodeficiency virus type 1 reverse transcriptase-resistant mutants explained by a mathematical model.Virus dynamics and drug therapyStochastic processes strongly influence HIV-1 evolution during suboptimal protease-inhibitor therapy.The Genetic Basis of HIV-1 Resistance to Reverse Transcriptase and Protease Inhibitors.Enhanced binding of azidothymidine-resistant human immunodeficiency virus 1 reverse transcriptase to the 3'-azido-3'-deoxythymidine 5'-monophosphate-terminated primer.Mathematical modeling of the interrelationship of CD4 lymphocyte count and viral load changes induced by the protease inhibitor indinavir.Broad spectrum of in vivo fitness of human immunodeficiency virus type 1 subpopulations differing at reverse transcriptase codons 41 and 215.Evolution of the human immunodeficiency virus envelope gene is dominated by purifying selection."Senseless" antiviral polyribonucleotides: poly (1-propargylinosinic acid).In vitro human immunodeficiency virus type 1 resistance selections with combinations of tenofovir and emtricitabine or abacavir and lamivudine.Mutations in the NS5B region of the hepatitis C virus genome correlate with clinical outcomes of interferon-alpha plus ribavirin combination therapy.Comparison of line probe assay (LIPA) and sequence analysis for detection of HIV-1 drug resistance.Anti-human immunodeficiency virus drug combination strategies.Reverse transcriptase mutations in HIV-1 infected patients treated with two nucleoside analogues: the SMART study.Frequency of drug-resistant variants of HIV-1 coexistent with wild-type in treatment-naive patients of India
P2860
Q27477742-6FF86378-6E27-4DFA-8F86-275F753A3719Q28379497-988BF560-CFB9-45E5-83CD-B53D3B45A956Q28533996-95A42836-F21F-48B8-9ACB-E253802BB929Q28544753-191E8F33-A49B-47B4-B917-3ECDD8C91CABQ33302143-257D541A-E29C-4E77-B945-2DC04E1FD85CQ33583299-851D73F8-BE88-4538-83AC-349B3C5CE557Q33784635-555492F4-051F-436E-A5CF-65D8DD521579Q33906239-146BA5D9-01D7-4B38-9366-8E9A77D1C523Q34717892-663276F2-3C4C-4EC1-9054-D68419A1621FQ35742512-C8E1F29D-5E3D-4164-9DDB-804025AC50C3Q35874788-257751C2-B2E6-4E48-B2AF-444ED39FB294Q36244920-2827C123-DA26-4D1C-96A5-0F9394BD3529Q36735938-FF7C4F81-B0BF-44AA-9DD1-550B4DE97033Q37018369-CDD71B40-44D2-4556-A21C-362B65B40002Q38336814-9068AA76-36FA-4C62-A2CB-E12EFBD9293EQ39556704-C208F89F-609A-4EA1-BD63-E645B561ECEDQ39879896-E71A519F-B938-4F32-B30B-BF3DA946A325Q40016358-C573572F-7EB0-4DFB-BA86-F797A2E4C67AQ40733824-8FBD075F-C5C1-44F2-A6EB-D9736F9B3D86Q40902737-90AF9908-723F-4859-AA3E-30C466A53233Q42994454-BB93937D-AFB9-414B-81CE-E4A03C22F313Q44443514-7BB79735-F2DD-4302-9899-6CF6C95D45C3Q45752028-2B87D7D7-CD3D-4381-8DB7-924D244B0EFFQ53940587-407FE6A9-7D86-49DB-8BB8-DA29CA330FE7Q56965171-A4A410A2-F74A-4081-A8F9-83F5AD82D7C9
P2860
Host-parasite dynamics and outgrowth of virus containing a single K70R amino acid change in reverse transcriptase are responsible for the loss of human immunodeficiency virus type 1 RNA load suppression by zidovudine.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 1996
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Host-parasite dynamics and out ...... oad suppression by zidovudine.
@en
Host-parasite dynamics and out ...... oad suppression by zidovudine.
@nl
type
label
Host-parasite dynamics and out ...... oad suppression by zidovudine.
@en
Host-parasite dynamics and out ...... oad suppression by zidovudine.
@nl
prefLabel
Host-parasite dynamics and out ...... oad suppression by zidovudine.
@en
Host-parasite dynamics and out ...... oad suppression by zidovudine.
@nl
P2093
P2860
P356
P1476
Host-parasite dynamics and out ...... oad suppression by zidovudine.
@en
P2093
Boucher CA
Schuurman R
Stilianakis NI
Veenstra J
de Boer RJ
de Jong MD
P2860
P304
P356
10.1073/PNAS.93.11.5501
P407
P577
1996-05-01T00:00:00Z